Get the Stockscreener App
3.56
1.39%
-0.05
After Hours:
3.56
Psyence Biomedical Ltd stock is traded at $3.56, with a volume of 119.58K.
It is down -1.39% in the last 24 hours and down -2.20% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$3.61
Open:
$3.61
24h Volume:
119.58K
Relative Volume:
0.06
Market Cap:
$6.65M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.95%
1M Performance:
-2.20%
6M Performance:
-0.50%
1Y Performance:
-93.83%
1-Day Range:
$3.45
$3.74
1-Week Range:
$3.24
$4.50
52-Week Range:
$2.36
$82.49
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
3.56 | 845.75K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Psyence Biomedical Ltd Stock (PBM) Latest News
Analyzing recovery setups for Psyence Biomedical Ltd. investorsJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
How analysts rate Psyence Biomedical Ltd. stock todayQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
Why retail investors favor Psyence Biomedical Ltd. Equity Warrant stockJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
How Psyence Biomedical Ltd. Equity Warrant stock performs in stagflationMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
How currency fluctuations impact Psyence Biomedical Ltd. stock2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Why Psyence Biomedical Ltd. Equity Warrant stock is a value investor pick2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Using data filters to optimize entry into Psyence Biomedical Ltd. Equity WarrantQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com
Psyence Biomedical Ltd. Equity Warrant stock daily chart insights2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Is Psyence Biomedical Ltd. stock a safe haven assetAnalyst Upgrade & Real-Time Stock Entry Alerts - newser.com
Detecting support and resistance levels for Psyence Biomedical Ltd. Equity Warrant2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Tick level data insight on Psyence Biomedical Ltd. volatility2025 Pullback Review & AI Driven Stock Reports - newser.com
Psyence Biomedical Ltd. Equity Warrant stock outlook for YEARWeekly Trading Summary & Verified Momentum Watchlists - newser.com
Can Psyence Biomedical Ltd. Equity Warrant hit a new high this month - newser.com
What data driven models say about Psyence Biomedical Ltd.’s futureMarket Growth Review & Risk Controlled Swing Alerts - newser.com
Is this a good reentry point in Psyence Biomedical Ltd.July 2025 Setups & AI Enhanced Trading Signals - newser.com
Psyence Biomedical's chairman, Jody Aufrichtig, assumes role of CEO - MarketScreener
Psyence Biomedical Announces Leadership Transition and Strategic Focus - TipRanks
Using Python tools to backtest Psyence Biomedical Ltd. strategiesPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Quantitative breakdown of Psyence Biomedical Ltd. recent move2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
Momentum divergence signals in Psyence Biomedical Ltd. Equity Warrant chartJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Using AI based signals to follow Psyence Biomedical Ltd.2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Does Psyence Biomedical Ltd. qualify in momentum factor screeningWeekly Trend Recap & Reliable Price Breakout Signals - newser.com
Why Psyence Biomedical Ltd. Equity Warrant is moving todayPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
How institutional ownership impacts Psyence Biomedical Ltd. stock2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Does Psyence Biomedical Ltd. show high probability of reboundJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Psyence Biomedical Ltd. (NASDAQ:PBM) Sees Significant Decrease in Short Interest - Defense World
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Key metrics from Psyence Biomedical Ltd. Equity Warrant’s quarterly dataJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
Is The Carlyle Group Inc a good long term investmentTechnology Stock Trends & Build a Smarter Portfolio Right Now - earlytimes.in
Developing predictive dashboards with Psyence Biomedical Ltd. Equity Warrant dataWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Psyence Biomedical Ltd Equity Warrant Stock Analysis and ForecastTechnical Breakout Signals & Achieve Explosive Results - earlytimes.in
What drives Psyence Biomedical Ltd stock priceAutomated Trading Signals & Free Stock Index Interpretations - earlytimes.in
Is Now a Good Time to Buy TAKE Solutions Limited Stock Key Indicators ReviewedMarket Entry Points & Free Extraordinary Earning Power - earlytimes.in
Psyence Biomedical Ltd Stock (PBM) Financials Data
There is no financial data for Psyence Biomedical Ltd (PBM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):